Cargando…

A systematic review of SARS-CoV-2 vaccine candidates

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that is highly pathogenic and has caused the recent worldwide pandemic officially named coronavirus disease (COVID-19). Currently, considerable efforts have been put into developing effective and safe drugs and vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yetian, Dai, Tong, Wei, Yujun, Zhang, Long, Zheng, Min, Zhou, Fangfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551521/ https://www.ncbi.nlm.nih.gov/pubmed/33051445 http://dx.doi.org/10.1038/s41392-020-00352-y

Ejemplares similares

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
por: Dong, Yetian, et al.
Publicado: (2020)

The way of SARS-CoV-2 vaccine development: success and challenges
por: Dong, Yetian, et al.
Publicado: (2021)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Identification of synthetic vaccine candidates against SARS CoV infection
por: Lien, Shu-Pei, et al.
Publicado: (2007)

SARS-CoV-2–Specific Vaccine Candidates; the Contribution of Structural Vaccinology
por: Pack, Su Min, et al.
Publicado: (2022)

Development of DNA Vaccine Candidate against SARS-CoV-2
por: Wang, Xingyun, et al.
Publicado: (2022)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

A candidate multi-epitope vaccine against SARS-CoV-2
por: Kar, Tamalika, et al.
Publicado: (2020)

A SARS-CoV-2 vaccine candidate: In-silico cloning and validation
por: Bhattacharya, Manojit, et al.
Publicado: (2020)

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
por: Tian, Jing-Hui, et al.
Publicado: (2021)

Evaluation of candidate vaccine approaches for MERS-CoV
por: Wang, Lingshu, et al.
Publicado: (2015)

New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
por: Ura, Takehiro, et al.
Publicado: (2021)

STING, a critical contributor to SARS-CoV-2 immunopathology
por: Li, Heyu, et al.
Publicado: (2022)

A highly immunogenic live-attenuated vaccine candidate prevents SARS-CoV-2 infection and transmission in hamsters
por: Li, Xiao-Feng, et al.
Publicado: (2022)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants
por: Gao, Feixia, et al.
Publicado: (2023)

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
por: Wang, Hui, et al.
Publicado: (2020)

A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2
por: Rohaim, Mohammed A., et al.
Publicado: (2020)

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
por: Poland, Gregory A, et al.
Publicado: (2020)

Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates
por: Behr, Marcel A, et al.
Publicado: (2020)

Bioinformatics Prediction of SARS-CoV-2 Epitopes as Vaccine Candidates for the Colombian Population
por: Montes-Grajales, Diana, et al.
Publicado: (2021)

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein
por: Lim, Heeji, et al.
Publicado: (2022)

Predicting Epitope Candidates for SARS-CoV-2
por: Agarwal, Akshay, et al.
Publicado: (2022)

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
por: Abdoli, Mohsen, et al.
Publicado: (2022)

Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice
por: Lázaro-Frías, Adrián, et al.
Publicado: (2022)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
por: Liu, Tong, et al.
Publicado: (2021)

Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2
por: Zhang, Panli, et al.
Publicado: (2022)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates
por: Gallagher, Molly E., et al.
Publicado: (2020)

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
por: Kyriakidis, Nikolaos C., et al.
Publicado: (2021)

In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine
por: Shehata, Mahmoud M., et al.
Publicado: (2021)

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
por: Liu, Yang, et al.
Publicado: (2022)

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
por: Liu, Yang, et al.
Publicado: (2022)

Candidate genes of SARS-CoV-2 gender susceptibility
por: Russo, Cristina, et al.
Publicado: (2021)

The Structural Characterization and Antigenicity of the S Protein of SARS-CoV
por: Li, Jingxiang, et al.
Publicado: (2003)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
por: Zhang, Xi-Ru, et al.
Publicado: (2023)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

MERS-CoV vaccine candidates in development: The current landscape
por: Modjarrad, Kayvon
Publicado: (2016)

Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models
por: Dey, Ayan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5lm1jb6imd881h185i0bfc818b